title: [Analysis of three-year survivors in patients with glioblastoma].
abstract: In eighty patients with glioblastomas surgically treated, there were nine patients (11%) survived for more than three years, and one of the 9 patients survived for six years. The contributing factors responsible for the longteun survival are: (a) extensive removal of the tumor; (b) radioterapy by linear accelarator (40-60Gy) after surgery; (c) post operative chemotherapy with BCNU.
authors.affiliation: Neurosurgery of Beijing Tiantan Hospital Affiliated to Captial University of Medicine.
authors.forename: X
authors.initials: X
authors.lastname: Shi
authors.forename: Z
authors.initials: Z
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000401:mortality* / Q000628:therapy; D002330:Carmustine / Q000627:therapeutic use; D002648:Child; D002681:China / Q000453:epidemiology; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005625:Frontal Lobe / Q000601:surgery; D005909:Glioblastoma / Q000401:mortality* / Q000628:therapy; D006801:Humans; D008297:Male; D011882:Radiotherapy, High-Energy; D015996:Survival Rate
chemical_list: D002330:Carmustine